Some of the names on the move ahead of the open.» Read More
What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.
Stocks rallied off a lower open Thursday as news of a Greek bailout and a sharp drop in jobless claims helped calm jittery investors — and put them in the mood to take some risks. Energy and industrials were the day's best performers; Financials were the worst.
Stocks opened lower Thursday as investors shrugged off an encouraging jobless report and news of a bailout for Greece. Financials took a hit, with JPMorgan leading the Dow's decline, as investors worry that debt problems in Europe could spread
Stock futures, already in positive territory on an apparent deal to rescue Greece, added to gains on good news from the labor market.
What follows is a roundup of corporate earnings reports for Thursday, Feb. 11
Retail sales, at down 0.3 percent, was below expectations of a gain of 0.5 percent, though November was revised upward, while first time unemployment claims rose slightly more than expected for the week.
Specialist business continues to consolidate: LaBranche trades up 30 percent after the close, in a deal that makes Barclay's designated market maker unit the largest DMM at the NYSE.
Specialist firm LaBranche halted for News Pending. Rumors that the firm has been for sale has been around for months now....
It appears that Washington is about to enact sweeping legislation that will be the greatest shift in public policy in decades. Yes, we can bemoan the lack of a completely private enterprise driven system but the reality is Big Brother is here and he's not going away. Without a doubt there will be implications for investors that need to be considered; and it's not all bad news from an investment perspective.
Warren Buffett agreed to buy one of America’s largest railroad companies in a deal valued at $44 billion. So what does Buffett’s move say about investing in America right now? David Pearl, co-CIO of Epoch Investment Partners, shared his insights.
Considering investors stepped into this market and bid shares higher even with unemployment at a 26-year high, is it safe to assume the bulls are back?
Critics have been saying for years that big pharma's been pi..., er, throwing away money on relatively unproductive research and development of new drugs. But a new study shows urine could eventually provide a new revenue stream.
Companies that provide laboratory services are down late in the day on talk that the the new Senate Finance Committee bill on healthcare will contain a co-pay for labs that will save some $20 billion over 10 years, which may put pressure on profits of those companies.
Unemployment hit 8.9 percent in April and some predict that number could climb to over 10 percent in 2009. But how far can this streamlining really go? See the S&P 500's leanest companies.
David Pearl of Epoch Investment Partners and David Moon of Moon Capital Management offered CNBC their insights. (Part 1: Medical Services)
Cramer makes the call on viewers' favorite stocks.
With stocks sharply lower today, shareholders need to protect their portfolios. So what are some of the best defensive stock picks? CNBC asked the experts.
Comcast, Lab Corp., Zimmer Holdings and others are all down today, but the still the market rallies. Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Recent spikes in Quest Diagnostics's stock price suggest the No. 1 medical testing company could be the latest buyout target in health care, but its valuation and debt load may keep private equity bidders at bay.
Specialist trading company LaBranche on Monday said it will review strategic alternatives for the business and said it expects a second-quarter loss.